Novo Nordisk shares slump after drug failure in Alzheimer’s trial
阿尔茨海默病药物试验失败，诺和诺德股价大跌

Outcome is blow to one of Europe’s largest listed companies
这一结果对诺和诺德造成重大打击，导致其股价一度下跌12%，最终收跌5.8%。